30.05.2013 Views

Alergia a sulfas - Associação Brasileira de Alergia e Imunopatologia

Alergia a sulfas - Associação Brasileira de Alergia e Imunopatologia

Alergia a sulfas - Associação Brasileira de Alergia e Imunopatologia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Alergia</strong> a <strong>sulfas</strong> Rev. bras. alerg. imunopatol. – Vol. 31, Nº 3, 2008 107<br />

não havendo, portanto, testes diagnósticos confirmatórios<br />

tanto in vivo quanto in vitro 23 . Quando não existe terapêutica<br />

alternativa em portadores <strong>de</strong> alergia à sulfonamidas,<br />

principamente, em pacientes com HIV-AIDS on<strong>de</strong> ela é<br />

muito mais prevalente, justifica-se o emprego cuidadoso<br />

dos vários protocolos <strong>de</strong> <strong>de</strong>ssensibilização padronizados,<br />

sempre em ambiente hospitalar dotado <strong>de</strong> UTI, e com a<br />

supervisão atenta do alergista especializado e experiente 24 .<br />

Referências<br />

1. Greenberger PA. Drug allergy. J Allergy Clin Immunol 2006;<br />

117 (2):S464-70.<br />

2. Grammer LC, Greenberger PA. Drug allergy and protocols for<br />

management of drug allergies. 3rd ed. Provi<strong>de</strong>nce (RI): Oceansi<strong>de</strong><br />

Pubs; 2003. p. 1-42.<br />

3. Gruchalla RS. Drug allergy. J Allergy Clin Immunol 2003; 111<br />

(suppl):S548-59.<br />

4. Neuman MG, Shear NH, Malkiewicz IM, Taeri M, Shapiro LE, et<br />

al. Immunopathogenesis of hypersensitivity syndrome reactions<br />

to sulfonami<strong>de</strong>s. Transl Res 2007; 149(5):243-53.<br />

5. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences<br />

in metabolism of sulfonami<strong>de</strong>s predisposing to idiosyncratic<br />

toxicity. Ann Intern Med 1986; 105:179-84.<br />

6. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E,<br />

Hennessy S, et al. Absence of cross-reactivity between sulfonami<strong>de</strong><br />

antibiotics and sulfonami<strong>de</strong> nonantibiotics. N Engl J<br />

Med 2003; 349:1628-35.<br />

7. Brackett CC. Sulfonami<strong>de</strong> allergy and cross-reactivity. Curr<br />

Allergy Asthma Rep 2007; 7 (1):41-8.<br />

8. Bourguignon R, Piérrard-Franchimont C, Paquet P, Piérard GE.<br />

DRESS syndrome to <strong>sulfas</strong>alzine. Rev Med Liege 2006; 61<br />

(9):643-8.<br />

9. Nishimura T, Obata H, Fujino H, Sonoda A, Sakamoto K, Mizuno<br />

C, et al. Case of ulcerative colitis associated with drug-induced<br />

hypersensitivity syndrome (DIHS) by salazosulfapyridine.<br />

Nippon Shokakibyo Gakkai Zasshi 2007; 104 (1):36-41.<br />

10. Chernecky C. Documented allergies of patients with cancer.<br />

Eur J Cancer Care 2003; 12 (4): 369-71.<br />

11. Ponka D. Approach to managing patients with sulfa allergy:<br />

use of antibiotic and nonantibiotic sulfonami<strong>de</strong>s. Can Fam<br />

Physician 2006; 52(11): 1434-38.<br />

12. Bernd LAG. <strong>Alergia</strong> a medicamentos. Rev. bras. alerg. imunopatol.<br />

2005; 28:125-32.<br />

13. Bernd LAG. <strong>Alergia</strong> Medicamentosa. In Geller M, Scheinberg M,<br />

ed Diagnóstico e Tratamento das Doenças Imunológicas, 1ª<br />

ed, Rio <strong>de</strong> Janeiro, Elsevier; 2005, p:133-42.<br />

14. Slatore C.G., Tilles S.A. Sulfonami<strong>de</strong> hypersensitivity. Immunol<br />

Allergy Clin North Am 2004; 24: 477-90.<br />

15. Yawalkar N, Shrikhan<strong>de</strong> M, Hari Y, Nievergelt H, Braathen LR,<br />

Pichler WJ. Evi<strong>de</strong>nce for a role for IL-5 and eotaxin in<br />

activating and recruiting eosinophils in drug-induced cutaneous<br />

eruptions. J.Allergy Clin Immunol 2000; 106 (6): 1171-6.<br />

16. Adkinson, Jr NF. Drug Allergy. In Middleton´s Allergy Principles<br />

& Practice 6 th ed. Mosby; 2003.pp.1679-84.<br />

17. Absar N., Daneshvar H., Beall G. Desensitization to trimethoprim/sulfametoxazole<br />

in HIV-infected patients. J Allergy Clin<br />

Immunol 1994; 93 (6);1001-5.<br />

18. Caumes E., Guermonprez G., Lecomte C., Katlama C., Fracis<br />

B. Efficacy and safety of <strong>de</strong>sensitization with sulfametoxazole<br />

and trimetoprim in 48 previously hypersensitive patients infected<br />

with HIV. Arch Dermatol 1997; 133 (4):465-9.<br />

19. Moreno JN., Poblete RB, Maggio C. Rapid oral <strong>de</strong>sensitization<br />

for sulfonami<strong>de</strong>s in patients with AIDS. Ann Allergy Asthma<br />

Immunol 1995; 74:140-6.<br />

20. Yoshizawa S., Yasouda A., Kikushi Y., Honda M., Gatanaga H.,<br />

Tachikawa N., et al. A 5-day course of oral <strong>de</strong>sensitization to<br />

trimetoprim/sulfamethoxazole (T/S) in patients with HIV type<br />

1 infection who were previously intolerant to T/S. Ann Allergy<br />

Asthma Immunol 2000; (3): 241-4.<br />

21. Cook D.E., Kossey J.L. Successful <strong>de</strong>sensitization to dapsone<br />

for Pneumocystis carinii prophylaxis in a HIV-positive patient.<br />

Ann Pharmacotherapy 1998; 32: 1302-5.<br />

22. Theodore C.M., Homes D., Rodgers M., McLean K. A. Cotrimazole<br />

<strong>de</strong>sensitization in HIV-seropositive patients. Int J STD<br />

AIDS 1998; 9:158-61.<br />

23. Gruchalla RS. Diagnosis of allergic reactions to sulfonami<strong>de</strong>s.<br />

Allergy 1999; 54 Suppl 58:28-32.<br />

24. Dibbern Jr DA, Montanaro A. Allergies to sulfonami<strong>de</strong> antibiotics<br />

and sulfur containing drugs. Ann Allergy Asthma Immunol<br />

2008; 100:91-100.<br />

Correspondência:<br />

Dr. Mario Geller<br />

Rua Viscon<strong>de</strong> <strong>de</strong> Pirajá 303 Conj 603 - Ipanema<br />

22410-001 - Rio <strong>de</strong> Janeiro - RJ<br />

Fone: 0XX-21-2287.2196<br />

Fax: 0XX-21-2287.4360<br />

e-mail: gellerm@attglobal.net

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!